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Abstract page (247 words) 1 
To prospectively evaluate the association of dietary calcium and magnesium intake with 2 
cancer incidence and mortality and all-cause mortality, the authors analyzed data of 3 
24,323 participants of the Heidelberg cohort of the European Prospective Investigation 4 
into Cancer and Nutrition (EPIC-Heidelberg), who were aged 35-64 years and cancer-5 
free at recruitment stage (1994-1998), using multivariate Cox regression models. After an 6 
average follow-up time of 11 years, 2,050 incident cancers were diagnosed and 513 7 
cancer deaths occurred (all-cause deaths = 1,161). Dietary calcium intake was inversely 8 
but not statistically significantly associated with colorectal cancer risk (hazard ratio (HR) 9 
for per 100-mg increase of intake: 0.95; 95% confidence interval (CI): 0.88, 1.02) and 10 
lung cancer risk (HR for per 100-mg increase of intake: 0.94; 95% CI: 0.87, 1.02). No 11 
statistically significant association was observed between dietary calcium intake and total 12 
cancer incidence. Compared with participants in the lowest quartile of dietary calcium 13 
intake, participants in the highest quartile had an increased risk of all-cause mortality (HR: 14 
1.20; 95% CI: 0.99, 1.45; Ptrend = 0.09; HR for per 100-mg increase of intake: 1.02; 95% 15 
CI: 1.00, 1.05).  Dietary magnesium intake was not statistically significantly related to 16 
any of the investigated outcomes. This prospective cohort study provides no strong 17 
evidence to support the preventive effect of dietary calcium and magnesium intake on 18 
cancer incidence and mortality. However, this study suggests a mild adverse effect of 19 
dietary calcium intake on all-cause mortality.  20 
 21 
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Introduction 23 
  3
Besides the importance in maintaining bone health, calcium is also a key nutrient 1 
involving in cell proliferation and carcinogenesis (1;2). Many epidemiological studies 2 
have evaluated the association between dietary calcium intake and risks of various cancer 3 
types. A growing body of evidence tends to suggest a protective effect of high dietary 4 
calcium intake on colorectal cancer (3-8) and breast cancer risk (9-14). Meanwhile, a 5 
number of studies have suggested that high calcium intake might increase the risk of 6 
prostate cancer (15-21).  7 
 8 
Magnesium is another important mineral with various metabolic and physiological 9 
functions that influence carcinogenesis (22-24). Although animal studies have 10 
consistently suggested an inhibitory effect of dietary magnesium intake on colorectal 11 
cancer risk (25-29), available epidemiological findings are few and far from being 12 
conclusive (30-33). Relationships between dietary magnesium intake and the risks of 13 
other common site-specific cancers have been scarcely reported in literatures.  14 
 15 
So far, only one study has reported the association between dietary calcium and 16 
magnesium intake and total cancer mortality (34). In that study, dietary calcium intake 17 
was not associated with total cancer mortality but significantly inversely associated with 18 
all-cause mortality, while dietary magnesium intake was not associated with either total 19 
cancer mortality or all-cause mortality.  20 
 21 
We hereby reported the associations of dietary calcium and magnesium intake with 22 
cancer incidence and mortality in a German prospective cohort.   23 
  4
Methods 1 
Study population   2 
Heidelberg is one of two German areas that joined the European Prospective 3 
Investigation into Cancer and Nutrition (EPIC) study. In 1994-1998, 11,928 men (aged 4 
40-64 years) and 13,612 women (aged 35-64 years) were recruited into the EPIC-5 
Heidelberg cohort. The recruitment procedures have been described elsewhere (35). The 6 
study protocol was approved by the Ethical Committee of the Heidelberg University 7 
Medical School. All participants provided informed consent. In the present study, we 8 
excluded participants whose total daily energy intake was in the top or bottom 0.5 sex-9 
specific percentile (men: < 887 / > 5,582 kcal/d; women: < 703 / > 4,381 kcal/d; n = 257) 10 
and participants with a diagnosis of cancer at recruitment stage (n = 953), leaving 24,323 11 
participants for analysis. 12 
 13 
Assessment of dietary calcium and magnesium intake and other exposures 14 
Diet in the last 12 months before recruitment was assessed using a self-administered food 15 
frequency questionnaire (FFQ) that had been validated by 12 24-hour dietary recalls 16 
(36;37). Dietary intakes of nutrients were derived using the German Dietary Nutrient 17 
Database BSL, version II.3. For the entire EPIC-Germany cohort, the main dietary 18 
sources of calcium were milk/milk products (39.9% for men and 38.7% for women) and 19 
non-alcoholic beverages (28.2% for men and 34.4% for women); the main dietary 20 
sources of magnesium were non-alcoholic beverages (25.1% for men and 33.7% for 21 
women) and cereal foods (22.6% for men and 20.6% for women) (38). Regular use of 22 
dietary supplements in the last 4 weeks before recruitment was assessed. However, 23 
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dosage data were not collected. Baseline demographic, lifestyle and other health-related 1 
data were collected in a face-to-face interview and a questionnaire survey.  2 
 3 
Ascertainment of disease outcomes 4 
Incident diseases and deaths that occurred during follow-up were reported by study 5 
participants or their next of kin in regular follow-up questionnaire surveys. Reported 6 
incident diseases were verified by reviewing medical records from hospitals. For 7 
deceased participants, the underlying cause of death was obtained from the official death 8 
certificate. In the present study, disease endpoints, coded using the International 9 
Classification of Disease (10th Revision, ICD-10), included: incident colorectal cancer 10 
(C18-C20), incident lung cancer (C34), incident prostate cancer (C61); incident breast 11 
cancer (C50); total cancer incidence and mortality (B21 and C00-C97), and all-cause 12 
mortality.  13 
 14 
Statistical analyses 15 
The residual method (39) was used to adjust dietary nutrient intakes for total energy 16 
intake. We categorized energy-adjusted dietary calcium and magnesium intake into 17 
quartiles using sex-specific cut-off points. To compare age-adjusted baseline 18 
characteristics across quartiles, we performed analysis of covariance and logistic 19 
regression (40). Multivariate Cox regression models were fitted to estimate hazard ratios 20 
(HRs) and 95% confidence intervals (CIs) for both quartiles and per 100-mg increase of 21 
dietary calcium and magnesium intake. For the former, likelihood ratio tests were 22 
performed to test the statistical significance of linear trend, with medians of quartiles 23 
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modeled as a continuous variable. For the latter, energy-adjusted calcium and magnesium 1 
intake were divided by 100 so that one unit represented an actual intake of 100 mg. 2 
Multivariate models adjusted for the following confounders: sex, age at recruitment 3 
(years), educational level (none/primary, technical/secondary, and university), physical 4 
activity (inactive, moderately inactive, moderately active, and active (41)), body mass 5 
index (BMI, kg/m2), waist-to-hip ratio, smoking categories (never smoker; former 6 
smoker, quit ≥ 10 years, quit < 10 years; and current smoker, ≤ 10, 11-20, > 20 7 
cigarettes/d), lifetime alcohol intake (g/d), dietary fiber intake (g/d), meat/meat product 8 
intake (g/d), and total energy intake (kcal/d). All these confounders, with exception of sex 9 
and calcium/vitamin D supplementation, altered the exposure-disease effect for 5% or 10 
greater. For the analysis of dietary calcium intake, dietary vitamin D and K2 intake 11 
(µg/day) and regular use of calcium/vitamin D supplements (yes/no) were additionally 12 
adjusted for. The reason for adjusting for dietary vitamin K2 intake is that vitamin K2 13 
intake, which closely correlates with dietary calcium intake (r = 0.63), was significantly 14 
inversely associated with lung and prostate cancer incidence and total cancer mortality in 15 
our cohort (42).  16 
 17 
For total cancer incidence and mortality and all-cause mortality, we further performed a 18 
sex-specific analysis and two-year lag analysis by excluding cancer cases or deaths that 19 
occurred in the first 2 years of follow-up. Two-sided P < 0.05 was considered statistically 20 
significant. SAS software (version 9.2; SAS Institute, Cary, NC) was used to perform all 21 
statistical analyses.  22 
  7
 1 
Results 2 
Age-adjusted baseline characteristics of participants are shown in Table 1. Participants 3 
with higher dietary calcium and magnesium intake were more likely to have a university 4 
degree, to be physically active, and to regularly take calcium/vitamin D supplements. 5 
Participants with higher dietary calcium intake also had a shorter smoking duration and a 6 
lower lifetime alcohol intake. Higher dietary calcium and magnesium intake were 7 
associated with certain favorable dietary factors, such as a higher dietary intake of 8 
vitamin D, fiber, but a lower intake of meat/meat products and total energy.       9 
   10 
During an average follow-up time of 11 years, 2,050 incident cancer cases were 11 
diagnosed and 513 cancer deaths occurred (all-cause deaths = 1,161). Dietary calcium 12 
intake in quartiles was not statistically significantly associated with total or common site-13 
specific cancer (colorectum, lung, prostate, and breast) incidence and total cancer 14 
mortality (Table 2). For all-cause mortality, participants in the highest quartile of dietary 15 
calcium intake had an increased risk of all-cause mortality than did those in the lowest 16 
quartile (HR: 1.20; 95% CI: 0.99, 1.45). We also ran models without adjusting for 17 
vitamin K2 intake, which revealed a statistically significantly inverse association of 18 
dietary calcium intake with lung cancer risk (HR for highest versus lowest quartile: 0.61; 19 
95% CI: 0.38, 0.98; Ptrend = 0.02), a non-significantly inverse association with prostate 20 
cancer risk (HR highest versus lowest quartile: 0.77; 95% CI: 0.56, 1.05; Ptrend = 0.07), 21 
and a non-significantly inverse association with total cancer mortality (HR for highest 22 
versus lowest quartile: 0.79, 95% CI: 0.61, 1.02; Ptrend = 0.07). When treated as a 23 
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continuous variable, per 100-mg increase of dietary calcium intake was inversely yet not 1 
statistically significantly associated with colorectal cancer risk (HR: 0.95; 95% CI: 0.88, 2 
1.02) and lung cancer risk (HR: 0.94; 95% CI: 0.87, 1.02). For all-cause mortality, the 3 
association was positive and borderline significant (HR: 1.02; 95% CI: 1.00, 1.05).  4 
 5 
As shown in Table 3, dietary magnesium intake, either in quartiles or as a continuous 6 
variable, was not statistically significantly associated with cancer incidence and mortality 7 
and all-cause mortality. For site-specific cancer incidence, per 100-mg increase of dietary 8 
magnesium intake was inversely but not statistically significantly associated with lung 9 
cancer risk (HR: 0.75; 95% CI: 0.51, 1.11).  10 
 11 
The sex-specific analysis and 2-year lag analysis did not produce substantially different 12 
results (data not shown).  13 
 14 
Discussion 15 
After an average follow-up time of 11 years of the EPIC-Heidelberg cohort, we observed 16 
a statistically non-significantly inverse association of dietary calcium intake with 17 
colorectal and lung risk and a borderline significant positive association with all-cause 18 
mortality. There were no statistically significant associations between dietary magnesium 19 
intake and cancer incidence and mortality and all-cause mortality.  20 
 21 
Dietary calcium intake 22 
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In the present study, dietary calcium intake was not associated with total cancer incidence, 1 
in contrast to a previous study showing a significantly inverse association in women but 2 
not in men (43). In our cohort, there was no statistically significant effect modification by 3 
sex (data not shown). Two meta-analyses of observational and interventional studies 4 
consistently suggest that high dietary calcium intake may reduce colorectal cancer risk 5 
(3;44). A possible mechanism for this protective effect is that free calcium in colon can 6 
bind bile acids and fatty acids and consequently prohibit the proliferation and 7 
differentiation of colorectal epithelial cell (45-49). In the present study, although we 8 
observed no significantly inverse association between the energy-adjusted dietary 9 
calcium intake and colorectal cancer risk, the absolute dietary calcium intake was 10 
significantly inversely associated with colorectal cancer risk, according to the standard 11 
model that controlled for total energy intake as a confounder (HR for highest versus 12 
lowest quartile: 0.46, 95% CI: 0.26, 0.79; Ptrend = 0.01).  13 
 14 
The relationship between dietary calcium intake and lung cancer risk has been rarely 15 
reported. Our finding of this non-significantly inverse association is not in agreement 16 
with the results of two previous observational studies, which showed either a significant 17 
positive association or a null association (43;50). However, in the model that ignored 18 
dietary vitamin K2 intake, the association was statistically significant, suggesting a 19 
confounding effect of dietary vitamin K2.   20 
 21 
We observed no statistically significant association between dietary calcium intake and  22 
prostate cancer risk, consistent with the result of a meta-analysis of 45 observational 23 
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studies (51), but not in line with the significant positive association reported in another 1 
meta-analysis of 10 prospective cohort studies, in which the median dietary calcium 2 
intake of the highest category ranged from 1,329 to 2,250 mg/d (21). In the EPIC-3 
Heidelberg cohort, the median dietary calcium intake of the highest quartile was 1,132 4 
mg/d. We may assume that only very high calcium intake can increase prostate cancer 5 
risk. However, a cohort study of Chinese men has suggested that dietary calcium intake 6 
may increase prostate cancer risk even at a substantially low level (52), implying that the 7 
real dose-response relationship could be complicated. On the other hand, the primary 8 
source of calcium in western diets is milk and milk products. Besides calcium, some 9 
other dairy components, such as saturated fatty, dairy protein, and hormone, are also risk 10 
factors for prostate cancer (15;53;54) and therefore may confound the association 11 
between dietary calcium intake and prostate cancer risk. In the present study, however, 12 
adjustment for milk/milk product intake did not substantially change the association, and 13 
milk/milk product intake itself was not statistically significantly associated with prostate 14 
cancer risk either. Some studies have suggested that high dietary calcium intake might 15 
have a more pronounced adverse effect on advanced/fatal prostate cancer risk (20;55;56). 16 
However, the present study observed no such a result (data not shown). Again, dietary 17 
vitamin K2 had a confounding effect on the association between dietary calcium intake 18 
and prostate cancer risk, which was suggested by the strengthened inverse association in 19 
the vitamin K2-unadjusted model.   20 
 21 
We observed no significantly inverse association between dietary calcium intake and 22 
breast cancer risk as was observed in previous studies (9-14). Some of these studies 23 
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showed that the inverse association was more pronounced for premenopausal women (10, 1 
11, 13, 14). In the present study, however, menopausal status did not modify the null 2 
association (data not shown).   3 
 4 
In the present study, the vitamin K2-unadjusted model produced an inverse association 5 
between dietary calcium intake and total cancer mortality, not supporting the null 6 
association reported in one prospective study of Swedish men  (34). In our cohort, dietary 7 
vitamin K2 intake was significantly inversely associated with overall cancer morality (HR 8 
for highest vs. lowest quartile: 0.72; 95% CI: 0.53, 0.85; ptrend = 0.03) (42). The 9 
substantially attenuated inverse association due to the adjustment for dietary vitamin K2 10 
intake suggests that dietary calcium intake may have no independent effect on overall 11 
cancer mortality. It is also notable that the mean energy-adjusted dietary calcium intake 12 
in the Swedish male cohort was much higher than that in our cohort (1,400 vs. 784 13 
mg/day for the entire cohort and 795 mg/day for the sub-cohort of men). In such 14 
a population that is less likely to have suboptimal calcium supply, an independent effect 15 
of dietary calcium intake, assuming it really exists, may be more difficult to detect. 16 
 17 
Dietary magnesium intake    18 
To the best of our knowledge, the association between dietary magnesium intake and 19 
total cancer incidence has never been reported before, and therefore the null association 20 
that we observed here needs to be confirmed or refuted by others. For site-specific cancer 21 
incidence, our result supports the finding of a Dutch cohort study that dietary magnesium 22 
intake was not associated with colorectal cancer risk (33). Other three prospective cohort 23 
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studies of women reported either a significantly inverse association or a null association 1 
(30-32). The average energy-adjusted dietary magnesium intake of these women cohorts 2 
were 289, 232, and 329 mg/d, respectively, comparable to that of our female sub-cohort 3 
(288 mg/d). However, the small number of incident colorectal cancer cases in our cohort 4 
does not permit a meaningful separate analysis for women.  5 
 6 
So far, only very few epidemiological studies have evaluated the association between 7 
dietary magnesium intake and lung, prostate, and breast cancer risk. In one case-control 8 
study, dietary magnesium intake was significantly inversely associated with lung cancer 9 
risk (57). In the present study, the association was inverse but not statistically significant. 10 
Another case-control study showed a moderate inverse association between magnesium 11 
level in drinking water and prostate cancer mortality (58). However, the relationship for 12 
magnesium intake from food has never been reported. As the present study suggested, 13 
dietary magnesium intake might have no association with prostate cancer risk, whether 14 
for overall prostate cancer or for advanced and non-advanced types separately. The null 15 
association of dietary magnesium intake with either cancer mortality or all-cause 16 
mortality in the present study is in agreement with the result of the Swedish male cohort 17 
(34). Based on limited findings, it seems that dietary magnesium intake might have no 18 
effect on cancer incidence and mortality. However, a solid conclusion could not be drawn 19 
until more evidence becomes available.     20 
 21 
Several limitations of the present study should be noted. Firstly, FFQ, even though it is 22 
usually validated before application, is a relatively rough instrument to quantify dietary 23 
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intakes of nutrients and thus the measurement errors are difficult to eliminate. Secondly, 1 
as shown in the present study, participants with higher dietary calcium intake were more 2 
likely to take calcium supplements. However, calcium intake from supplements was not 3 
quantified. In addition, not taking into account calcium intake from drinking water might 4 
also be problematic, although we have no knowledge on its relationship with calcium 5 
intake from foods. Lastly, some important cancer risk factors, such as family history and 6 
cancer screening, were not adjusted for in the present study, and therefore residual 7 
confounding may exist. However, we additionally adjusted for dietary vitamin K2 intake, 8 
an important confounder that had not been controlled for in any of previous studies.  9 
 10 
In summary, this German prospective cohort study provides no strong evidence to 11 
support that high dietary calcium and magnesium intake in the intake range observed in a 12 
German population may reduce the risk of cancer incidence, in total or for common site-13 
specific types, and overall cancer mortality. 14 
 15 
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Table 1. Age-adjusted baseline characteristics of  the EPIC-Heidelberg participants by sex-specific quartiles of dietary calcium and  
magnesium intake, 1994-1998 
 Quartiles of calcium intake  Quartiles of magnesium intake 
 Q1  Q2  Q3 Q4  Q1  Q2  Q3 Q4  
No. of participants (n) 6,070 6,095 6,072 6,086  6,143 6,039 6,048 6,093 
Men (%) 47.0 47.0 46.8 47.0  46.9 47.8 46.7 46.4 
Age at recruitment (years) 51.3 50.7 50.4 50.7  50.1 50.7 51.0 51.2† 
University degree (%) 21.2 28.6 33.0 37.6†  22.2 29.9 32.6 35.8† 
Physically active (%) 22.4 24.0 24.2 28.8†  22.0 23.2 24.7 29.5† 
BMI (kg/m2) 26.2 26.2 26.1 26.0†  26.3 26.2 26.2 25.8† 
Waist-to-hip ratio 0.87 0.87 0.87 0.86†  0.87 0.87 0.87 0.86† 
Smoking duration (years) 13.6 12.0 11.8 11.8†  12.4 12.0 12.3 12.5 
Lifetime alcohol intake (g/d) 21.7 17.8 15.6 13.9†  15.4 16.9 17.9 18.6† 
Dietary calcium intake (mg/d)a 512 675 820 1,131†  655 745 808 930† 
Dietary magnesium intake (mg/d)a 293 308 322 345†  261 299 328 381† 
Vitamin D (µg/d)a 3.0 3.3  3.3 3.4†  3.2 3.2 3.3 3.3† 
Vitamin K2 (µg/d)a 28.0 33.5 37.9 44.3†  36.6 37.0 35.8 34.2† 
Dietary fiber (g/d)a 18.4 19.9 20.5 21.0†  16.6 18.7 20.6 24.0† 
Meat/meat product intake (g/d) 119.7 103.8 92.1 76.4†  110.2 106.3 96.5 77.8† 
Total energy intake (kcal/d) 1,974 1,971 1,929 1,954†  1,960 1,957 1,961 1,950 
Regular use of Ca/vitamin D supplementsb, (%) 7.5 8.3 9.6 11.5†  7.4 8.4 9.4 11.4† 
Participants with a diagnosis of cancer at recruitment and participants whose total daily energy intake was in the top or bottom 0.5 sex-specific 
percentile (men: < 887 / > 5,582 kcal/d; women: < 703 / > 4,381 kcal/d) were excluded.  
BMI body mass index; EPIC European Prospective Investigation into Cancer and Nutrition 
† Ptrend < 0.05, tested by using Cochran-Armitage method for categorical variables and generalized linear model for continuous variables. Values 
are means or percentages. 
a
 Adjusted for total energy intake using the residual method.  
b Including multivitamins/minerals. 
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Table 2. Multivariate HRs and 95% CIs for cancer incidence by quartiles of dietary calcium intake in the EPIC-Heidelberg cohort, 1994-2010 
 
Quartiles of dietary calcium intake  
  Ptrend 
Intake as  
continuous variablea Q1 Q2 Q3 Q4 
Overall cancer incidence       
  No. of cases  555 511 489 495   
  HR (95% CI) 1.00 (ref) 1.01 (0.89-1.15) 1.01 (0.89-1.16) 1.04 (0.90-1.20) 0.75 1.01 (0.99-1.03) 
Colorectal cancer       
  No. of cases 59 55 47 40   
  HR 1.00 (ref) 1.03 (0.71-1.52) 0.93 (0.61-1.42) 0.80 (0.50-1.30) 0.32 0.95 (0.88-1.02) 
Lung cancer       
  No. of cases 67 28 25 27   
  HR (95% CI) 1.00 (ref) 0.66 (0.41-1.05) 0.64 (0.38-1.07) 0.71 (0.41-1.21) 0.50 0.94 (0.87-1.02) 
Prostate cancer       
  No. of men 2,854 2,866 2,840 2,861   
  Mean intake (mg/d) 510 678 830 1163   
  No. of cases  102 103 98 84   
  HR (95% CI) 1.00 (ref) 1.07 (0.80-1.42) 1.04 (0.77-1.41) 0.83 (0.58-1.18) 0.23 0.99 (0.94-1.03) 
Breast cancer       
  No. of women 3,216 3,229 3,232 3,225   
  Mean intake (mg/d) 515 673 812 1102   
  No. of cases  102 99 106 108   
  HR (95% CI) 1.00 (ref) 0.95 (0.72-1.27) 0.98 (0.73-1.31) 0.98 (0.71-1.35) 0.93 1.02 (0.97-1.06) 
Total cancer mortality       
  No. of cases  173 118 113 109   
  HR (95% CI) 1.00 (ref) 0.85 (0.66-1.08) 0.88 (0.68-1.15) 0.90 (0.68-1.20) 0.52 0.98 (0.95-1.03) 
All-cause mortality       
  No. of cases  350 288  240 283   
  HR (95% CI) 1.00 (ref) 1.03 (0.88-1.22) 0.96 (0.80-1.14) 1.20 (0.99-1.45) 0.09 1.02 (1.00-1.05) 
Adjusted for sex, age at recruitment, educational level, physical activity, BMI, waist-to-hip ratio, smoking category, lifetime alcohol intake, meat/meat product intake, 
dietary intakes of vitamin D, vitamin K2, and fiber, total energy intake and regular use of Ca/vitamin D supplements. For lung cancer incidence, dietary magnesium 
intake was additionally adjusted for.Abbreviations:  
BMI body mass index; EPIC European Prospective Investigation into Cancer and Nutrition,  HR hazard ratio.  
Participants with a diagnosis of cancer at recruitment and participants whose total daily energy intake was in the top or bottom 0.5 sex-specific percentile (men: < 887 
/ > 5,582 kcal/d; women: < 703 / > 4,381 kcal/d) were excluded.   
a
 For per 100-mg increase of dietary calcium intake. 
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Table 3. Multivariate HRs and 95% CIs for cancer incidence by quartiles of dietary magnesium intake in the EPIC-Heidelberg cohort, 1994-2010 
 
Quartiles of dietary magnesium intake  
  Ptrend 
Intake as  
continuous variablea Q1 Q2 Q3 Q4 
Overall cancer incidence       
  No. of cases  513 505 463 569   
  HR (95% CI) 1.00 (ref) 0.99 (0.88-1.13) 0.90 (0.79-1.03) 1.12 (0.97-1.29) 0.19 1.06 (0.95-1.18) 
Colorectal cancer       
  No. of cases 48 54 51 48   
  HR 1.00 (ref) 1.18 (0.79-1.76) 1.18 (0.76-1.81) 1.27 (0.76-2.10) 0.41 1.14 (0.78-1.68) 
Lung cancer       
  No. of cases 47 34 34 32   
  HR (95% CI) 1.00 (ref) 0.80 (0.51-1.26) 0.88 (0.55-1.42) 0.83 (0.49-1.43) 0.52 0.75 (0.51-1.11) 
Prostate cancer       
  No. of men 2,883 2,887 2,824 2,827   
  Mean intake (mg/d) 287 330 362 421   
  No. of cases  88 108 84 107   
  HR (95% CI) 1.00 (ref) 1.19 (0.89-1.58) 0.91 (0.66-1.25) 1.07 (0.76-1.49) 0.96 0.96 (0.76-1.21) 
Breast cancer       
  No. of women 3,260 3,152 3,224 3,266   
  Mean intake (mg/d) 235 271 298 347   
  No. of cases  113 101 90 111   
  HR (95% CI) 1.00 (ref) 0.93 (0.70-1.22) 0.77 (0.57-1.04) 0.97 (0.69-1.35) 0.68 0.90 (0.67-1.20) 
Total cancer mortality       
  No. of cases  139 109 127 138   
  HR (95% CI) 1.00 (ref) 0.80 (0.62-1.03) 0.95 (0.74-1.23) 1.04 (0.79-1.36) 0.62 1.04 (0.85-1.28) 
All-cause mortality       
  No. of cases  321 267 285 288   
  HR (95% CI) 1.00 (ref) 0.88 (0.75-1.04) 0.99 (0.84-1.17) 1.04 (0.87-1.25) 0.41 1.09 (0.95-1.25) 
Adjusted for sex, age at recruitment, educational level, physical activity, BMI, waist-to-hip ratio, smoking category, lifetime alcohol intake, meat/meat product intake, 
dietary intake of fiber, and total energy intake. For colorectal, lung, and prostate cancer incidence and total cancer mortality, dietary calcium and vitamin K2 intake were 
additionally adjusted for. 
Participants with a diagnosis of cancer at recruitment and participants whose total daily energy intake was in the top or bottom 0.5 sex-specific percentile (men: < 887 / 
> 5,582 kcal/d; women: < 703 / > 4,381 kcal/d) were excluded. 
BMI body mass index; EPIC European Prospective Investigation into Cancer and Nutrition,  HR hazard ratio.  
a
 For per 100-mg increase of dietary magnesium intake. 
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